Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors-Reference-Cited by-同舟云学术

Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors

Published:2022-11 Issue:6 Volume:48 Page:101405
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Scheen André J.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference118 articles.

1. Electrical features of the diabetic myocardium. Arrhythmic and cardiovascular safety considerations in diabetes;Gallego;Front Pharmacol,2021

2. Type 2 diabetes and causes of sudden cardiac death: a systematic review;Singh;Cureus,2021

3. Sudden cardiac death and diabetes mellitus;Vasiliadis;J Diabetes Complications,2014

4. Sudden cardiac death in patients with diabetes mellitus and chronic heart failure;Walker;Diab Vasc Dis Res,2015

5. Diabetes mellitus and the risk of sudden cardiac death: A systematic review and meta-analysis of prospective studies;Aune;Nutr Metab Cardiovasc Dis,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sudden cardiac death due to ventricular arrhythmia in diabetes mellitus: A bench to bedside review;Heart Rhythm;2024-06

2. Glycemic control and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: insight from ventricular remodeling using cardiac MRI;Cardiovascular Diabetology;2024-04-29

3. Metformin treatment is associated with improved survival in diabetic patients hospitalized with acute heart failure: A prospective observational study using the Korean acute heart failure registry data;Diabetes & Metabolism;2024-01

4. Quantitative Assessment of Mitochondrial Morphology and Electrophysiological Function in the Diabetic Heart;Methods in Molecular Biology;2024

5. Associations between Oral Glucose-Lowering Agents and Increased Risk for Life-Threatening Arrhythmias in Patients with Type 2 Diabetes Mellitus—A Literature Review;Medicina;2023-10-02